TAK Stock Takeda Pharmaceutical (TAK, $18.32) was a top quarterly gainer, rising +16.84%
at Tickeron.com
Loading...
Takeda Pharmaceutical (TAK, $18.32) was one of top quarterly gainers, jumping +1 to $18.32 per share. A.I.dvisor analyzed 84 stocks in the Pharmaceuticals: Generic Industry over the last three months, and discovered that of them (6) charted an Uptrend while of them (3) trended down.
Aroon Indicator for TAK shows an upward move is likely
TAK's Aroon Indicator triggered a bullish signal on September 14, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 273 similar instances where the Aroon Indicator showed a similar pattern. In 149 of the 273 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 55%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 29 of 65 cases where TAK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 45%.
The Momentum Indicator moved above the 0 level on September 11, 2026. You may want to consider a long position or call options on TAK as a result. In 38 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 40%.
The 50-day moving average for TAK moved above the 200-day moving average on August 10, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where TAK advanced for three days, in 152 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
Bearish Trend Analysis
The 10-day RSI Indicator for TAK moved out of overbought territory on September 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 15 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
The Moving Average Convergence Divergence Histogram (MACD) for TAK turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 17 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 40%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TAK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 45%.
TAK broke above its upper Bollinger Band on August 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 2 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.196) is normal, around the industry mean (46.800). P/E Ratio (41.878) is within average values for comparable stocks, (93.608). Projected Growth (PEG Ratio) (0.405) is also within normal values, averaging (1.957). Dividend Yield (0.034) settles around the average of (0.030) among similar stocks. P/S Ratio (1.935) is also within normal values, averaging (178.849).
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. TAK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 46 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.